08158.HK
China Regenerative Medicine International Limited
HKSE · Healthcare · Biotechnology · HK
HKD 0.25
−5.66%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 2.55x
- PEG TTM
- 0.03x
- Price / book
- 1.34x
- Price / sales
- 0.71x
- Price / cash flow
- 4.87x
Enterprise value
- Enterprise value
- HKD 112.5M
- EV / sales
- 1.05x
- EV / EBITDA
- 4.76x
- EV / EBIT
- 11.65x
- Market cap
- HKD 76.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026